XML 20 R5.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2022   166,793,320      
Beginning balance at Dec. 31, 2022 $ 294,958 $ 1,668 $ 1,450,239 $ (1,148,545) $ (8,404)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock, net of offering expenses (in shares)   8,249,261      
Issuance of common stock, net of offering expenses 15,106 $ 83 15,023    
Issuance of common stock upon exercise of stock options and vesting of restricted stock units, net of tax (in shares)   1,481,508      
Issuance of common stock upon exercise of stock options and vesting of restricted stock units, net of tax (1,404) $ 15 (1,419)    
Issuance of common stock under employee stock purchase plan (in shares)   755,586      
Issuance of common stock under employee stock purchase plan 719 $ 7 712    
Stock-based compensation 21,256   21,256    
Foreign currency translation adjustment 981       981
Net pension (loss) gain 2       2
Net unrealized (loss) gain on marketable securities, net of tax 840       840
Net income (loss) (197,536)     (197,536)  
Ending balance (in shares) at Sep. 30, 2023   177,279,675      
Ending balance at Sep. 30, 2023 134,922 $ 1,773 1,485,811 (1,346,081) (6,581)
Beginning balance (in shares) at Jun. 30, 2023   177,074,546      
Beginning balance at Jun. 30, 2023 233,642 $ 1,771 1,479,725 (1,241,918) (5,936)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options and vesting of restricted stock units, net of tax (in shares)   205,129      
Issuance of common stock upon exercise of stock options and vesting of restricted stock units, net of tax (101) $ 2 (103)    
Stock-based compensation 6,189   6,189    
Foreign currency translation adjustment (1,144)       (1,144)
Net pension (loss) gain 5       5
Net unrealized (loss) gain on marketable securities, net of tax 494       494
Net income (loss) (104,163)     (104,163)  
Ending balance (in shares) at Sep. 30, 2023   177,279,675      
Ending balance at Sep. 30, 2023 134,922 $ 1,773 1,485,811 (1,346,081) (6,581)
Beginning balance (in shares) at Dec. 31, 2023   178,133,548      
Beginning balance at Dec. 31, 2023 82,887 $ 1,781 1,492,077 (1,406,376) (4,595)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock, net of offering expenses (in shares)   24,761,905      
Issuance of common stock, net of offering expenses 21,788 $ 248 21,540    
Issuance of common stock upon exercise of pre-funded warrants (in shares)   3,809,523      
Issuance of common stock upon exercise of pre-funded warrants 71 $ 38 33    
Issuance of common stock upon exercise of stock options and vesting of restricted stock units, net of tax (in shares)   1,535,250      
Issuance of common stock upon exercise of stock options and vesting of restricted stock units, net of tax (684) $ 15 (699)    
Issuance of common stock under employee stock purchase plan (in shares)   379,486      
Issuance of common stock under employee stock purchase plan 146 $ 4 142    
Stock-based compensation 9,099   9,099    
Foreign currency translation adjustment 371       371
Net pension (loss) gain 234       234
Net unrealized (loss) gain on marketable securities, net of tax (233)       (233)
Net income (loss) (74,545)     (74,545)  
Ending balance (in shares) at Sep. 30, 2024   208,619,712      
Ending balance at Sep. 30, 2024 39,134 $ 2,086 1,522,192 (1,480,921) (4,223)
Beginning balance (in shares) at Jun. 30, 2024   208,201,140      
Beginning balance at Jun. 30, 2024 23,690 $ 2,082 1,519,084 (1,491,593) (5,883)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options and vesting of restricted stock units, net of tax (in shares)   418,572      
Issuance of common stock upon exercise of stock options and vesting of restricted stock units, net of tax (203) $ 4 (207)    
Stock-based compensation 3,315   3,315    
Foreign currency translation adjustment 1,664       1,664
Net pension (loss) gain (4)       (4)
Net unrealized (loss) gain on marketable securities, net of tax 0        
Net income (loss) 10,672     10,672  
Ending balance (in shares) at Sep. 30, 2024   208,619,712      
Ending balance at Sep. 30, 2024 $ 39,134 $ 2,086 $ 1,522,192 $ (1,480,921) $ (4,223)